Vector prostate biopsy: new research shows high detection rates and tolerability with minimal complications
2 min read
As the UK’s leading independent cancer care provider, we are always looking for new ways to improve patient outcomes and experience.
Transperineal Vector prostate biopsy using local anaesthetic is a novel and innovative technique for prostate cancer assessment. It’s a convenient alternative to transrectal or transperineal (TP) biopsies using general anaesthetic.
Building on the evidence base for TP prostate biopsies, the Vector prostate biopsy approach combines MRI US fusion TP template prostate biopsy with VTRAX electromagnetic needle tracking without direct view. This brings the benefits of classic fusion TP biopsy, but with only two locally anaesthetised entry points while the probe and fusion remain stable.
A recent publication in the European Association of Urology of a study conducted at our centres in Cambridge and Windsor shows this technique is feasible and tolerable with high cancer detection rates, while maintaining patient comfort and minimal complications.
We’re excited to share these results with the world and look forward to continuing our research and innovation in prostate cancer, and all cancers, for patients around the world.